Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells

Mohammad A. Obeid; Ashref Elburi; Louise C. Young; Alexander B. Mullen; Rothwelle J. Tate; Valerie A. Ferro

doi:10.1021/acs.molpharmaceut.7b00352

Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells

Mohammad A. Obeid, Ashref Elburi, Louise C. Young, Alexander B. Mullen, Rothwelle J. Tate, Valerie A. Ferro

Research output: Contribution to journal › Article

13 Citations (Scopus)

26 Downloads (Pure)

Abstract

Small interfering RNAs (siRNA) have a broad potential as therapeutic agents to reversibly silence any target gene of interest. The clinical application of siRNA requires the use of safe and effective delivery systems. In this study, we investigated the use of nonionic surfactant vesicles (NISV) for the delivery of siRNA. Different types of NISV formulations were synthesized by microfluidic mixing and then evaluated for their physiochemical properties and cytotoxicity. The ability of the NISV to carry and transfect siRNA targeting green fluorescent protein (GFP) into A549 that stably express GFP (copGFP-A549) was evaluated. Flow cytometry and Western blotting were used to study the GFP expression knockdown, and significant knockdown was observed as a result of siRNA delivery to the cells by NISV. This occurred in particular when using Tween 85, which was able to achieve more than 70% GFP knockdown. NISV were thus demonstrated to provide a promising and effective platform for therapeutic delivery of siRNA.

Original language	English
Pages (from-to)	2450-2458
Number of pages	9
Journal	Molecular Pharmaceutics
Volume	14
Issue number	7
Early online date	1 Jun 2017
DOIs	https://doi.org/10.1021/acs.molpharmaceut.7b00352
Publication status	Published - 3 Jul 2017

Keywords

drug delivery
microfluidics
nonionic surfactant vesicles
RNA interference

Access to Document

10.1021/acs.molpharmaceut.7b00352

Obeid-etal-MP-2017-Formulation-of-Nonionic-Surfactant-Vesicles-NISV-prepared-by-microfluidicsAccepted author manuscript, 1.16 MB

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells'. Together they form a unique fingerprint.

Profiles

Valerie Ferro

v.a.ferro@strath.ac.uk

Strathclyde Institute Of Pharmacy And Biomedical Sciences - Senior Lecturer

Person: Academic

Research Output

13 Citations
1 Article

Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods

Obeid, M. A., Gebril, A. M., Tate, R. J., Mullen, A. B. & Ferro, V. A., 3 Feb 2017, In : International Journal of Pharmaceutics. p. 1-23 23 p.

Research output: Contribution to journal › Article

Open Access

File

11 Citations (Scopus)

22 Downloads (Pure)

Cite this

Obeid, M. A., Elburi, A., Young, L. C., Mullen, A. B., Tate, R. J., & Ferro, V. A. (2017). Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells. Molecular Pharmaceutics, 14(7), 2450-2458. https://doi.org/10.1021/acs.molpharmaceut.7b00352

@article{8bf9d71831804fc1b607bd25f2ce3212,

title = "Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells",

abstract = "Small interfering RNAs (siRNA) have a broad potential as therapeutic agents to reversibly silence any target gene of interest. The clinical application of siRNA requires the use of safe and effective delivery systems. In this study, we investigated the use of nonionic surfactant vesicles (NISV) for the delivery of siRNA. Different types of NISV formulations were synthesized by microfluidic mixing and then evaluated for their physiochemical properties and cytotoxicity. The ability of the NISV to carry and transfect siRNA targeting green fluorescent protein (GFP) into A549 that stably express GFP (copGFP-A549) was evaluated. Flow cytometry and Western blotting were used to study the GFP expression knockdown, and significant knockdown was observed as a result of siRNA delivery to the cells by NISV. This occurred in particular when using Tween 85, which was able to achieve more than 70{\%} GFP knockdown. NISV were thus demonstrated to provide a promising and effective platform for therapeutic delivery of siRNA.",

keywords = "drug delivery, microfluidics, nonionic surfactant vesicles, RNA interference",

author = "Obeid, {Mohammad A.} and Ashref Elburi and Young, {Louise C.} and Mullen, {Alexander B.} and Tate, {Rothwelle J.} and Ferro, {Valerie A.}",

year = "2017",

month = "7",

day = "3",

doi = "10.1021/acs.molpharmaceut.7b00352",

language = "English",

volume = "14",

pages = "2450--2458",

journal = "Molecular Pharmaceutics",

issn = "1543-8384",

publisher = "American Chemical Society",

number = "7",

}

TY - JOUR

T1 - Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells

AU - Obeid, Mohammad A.

AU - Elburi, Ashref

AU - Young, Louise C.

AU - Mullen, Alexander B.

AU - Tate, Rothwelle J.

AU - Ferro, Valerie A.

PY - 2017/7/3

Y1 - 2017/7/3

N2 - Small interfering RNAs (siRNA) have a broad potential as therapeutic agents to reversibly silence any target gene of interest. The clinical application of siRNA requires the use of safe and effective delivery systems. In this study, we investigated the use of nonionic surfactant vesicles (NISV) for the delivery of siRNA. Different types of NISV formulations were synthesized by microfluidic mixing and then evaluated for their physiochemical properties and cytotoxicity. The ability of the NISV to carry and transfect siRNA targeting green fluorescent protein (GFP) into A549 that stably express GFP (copGFP-A549) was evaluated. Flow cytometry and Western blotting were used to study the GFP expression knockdown, and significant knockdown was observed as a result of siRNA delivery to the cells by NISV. This occurred in particular when using Tween 85, which was able to achieve more than 70% GFP knockdown. NISV were thus demonstrated to provide a promising and effective platform for therapeutic delivery of siRNA.

AB - Small interfering RNAs (siRNA) have a broad potential as therapeutic agents to reversibly silence any target gene of interest. The clinical application of siRNA requires the use of safe and effective delivery systems. In this study, we investigated the use of nonionic surfactant vesicles (NISV) for the delivery of siRNA. Different types of NISV formulations were synthesized by microfluidic mixing and then evaluated for their physiochemical properties and cytotoxicity. The ability of the NISV to carry and transfect siRNA targeting green fluorescent protein (GFP) into A549 that stably express GFP (copGFP-A549) was evaluated. Flow cytometry and Western blotting were used to study the GFP expression knockdown, and significant knockdown was observed as a result of siRNA delivery to the cells by NISV. This occurred in particular when using Tween 85, which was able to achieve more than 70% GFP knockdown. NISV were thus demonstrated to provide a promising and effective platform for therapeutic delivery of siRNA.

KW - drug delivery

KW - microfluidics

KW - nonionic surfactant vesicles

KW - RNA interference

UR - http://www.scopus.com/inward/record.url?scp=85021701734&partnerID=8YFLogxK

U2 - 10.1021/acs.molpharmaceut.7b00352

DO - 10.1021/acs.molpharmaceut.7b00352

M3 - Article

AN - SCOPUS:85021701734

VL - 14

SP - 2450

EP - 2458

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 7

ER -